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Abstract: Background: The increasing prevalence of diabetes in the United Kingdom and worldwide
calls for new approaches to its management, and diets with low glycaemic index have been proposed
as a useful means for managing glucose response. However, there are conflicting reports and
differences in the results of studies in terms of their effectiveness. Furthermore, the impact of
low-glycaemic index diets and their long-term use in patients with type 2 diabetes remains unclear.
Objectives: The objective of this study was to conduct a systematic review and meta-analysis of
the effect of low-glycaemic index diets in patients with type 2 diabetes. Methods: Search methods:
Randomised controlled studies were selected from a number of databases (EBSCOHost with links
to Health Research databases, PubMed, and grey literature) based on the Population, Intervention,
Comparator, Outcomes and Study designs (PICOS) framework. The search terms included synonyms
and Medical Subject Headings (MeSH) and involved the use of Boolean operators (AND/OR) which
allowed the combination of words and search terms. Selection criteria: As per the selection criteria,
the following types of articles were selected: studies on randomised controlled trials, with year
of publication between 2008 and 2018, including patients with type 2 diabetes. Thus, studies
involving patients with gestational and type 1 diabetes were excluded, as were observational studies.
Nine articles which met the inclusion criteria were selected for the systematic review, whereas
only six articles which met the criteria were included in the meta-analysis. Data collection and
analysis: Studies were evaluated for quality and risk of bias. In addition, heterogeneity, meta-analysis,
and sensitivity tests of the extracted data were carried out using Review Manager 5.3 (Review
Manager, 2014). Results: The findings of the systematic review showed that the low-glycaemic
index (low-GI) diet resulted in a significant improvement (<0.05) in glycated haemoglobin (HbA1c)
in two studies: low-GI diet ∆ = −0.5% (95% CI, −0.61% to −0.39%) vs. high-cereal fibre diet
∆ = −0.18% (95% CI, −0.29% to −0.07%); and low-GI legume diet ∆ = −0.5% (95%, −0.6%
to −0.4%) vs. high-wheat fibre diet ∆ = −0.3% (95% Cl, −0.4 to −0.2%). There was a slight
improvement in one study (low glycaemic response = 6.5% (6.3–7.1) vs. control = 6.6% (6.3–7.0) and no
significant difference (p > 0.05) in four studies compared with the control diet. Four studies showed
improvements in fasting blood glucose in low-GI diets compared to higher-GI diets or control: low-GI
diet = 150.8 ± 8.7 vs. higher-GI diet = 157.8 ± 10.4 mg/dL, mean ± SD p = 0.43; low-GI diet = 127.7
vs. high-cereal fibre diet = 136.8 mg/dL, p = 0.02; low-GI diet = 6.5 (5.6–8.4) vs. standard diabetic
diet = 6.7 (6.1–7.5) mmol/L, median and interquartile range p > 0.05; and low-GI diet = 7.3 ± 0.3 vs.
conventional carbohydrate exchange diet = 7.7 ± 0.4 mmol/L, mean ± SEM (Standard Error of Mean)
p < 0.05. The results of the meta-analysis and sensitivity tests demonstrated significant differences
(p < 0.001 and p < 0.001, respectively) between the low-GI diet and the higher-GI diet or control
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diet in relation to glycated haemoglobin. Differences between the low-GI diet and higher-GI diet or
control were significant (p < 0.05) with respect to the fasting blood glucose following meta-analysis.
Conclusion: The low-GI diet is more effective in controlling glycated haemoglobin and fasting blood
glucose compared with a higher-GI diet or control in patients with type 2 diabetes.
Keywords: glycaemic index; glycated haemoglobin; fasting blood glucose; type 2 diabetes;
randomised controlled trials; meta-analysis; systematic review
1. Introduction
The increasing prevalence of diabetes and its impact on morbidity and mortality have become
global problems [1,2]. About 422 million adults worldwide were reported to live with diabetes in
2016, and the global prevalence rose from 4.7% in 1980 to 8.5% in 2014 [1]. In the United Kingdom,
the prevalence of type 2 diabetes more than doubled from 2.39% in the year 2000 to 5.32% in 2013 [2].
The management of type 2 diabetes and its related complications, including retinopathy, kidney
dysfunction, neuropathy, and foot problems accounts for about 10% of the entire National Health
Service (NHS) budget in the UK [2]. Presently, 11% of U.S. adult population has diabetes and the
total estimated costs associated with the condition in 2012 were US $245 billion due to direct medical
costs and reduced worker productivity [3]. Several factors, including genetic predisposition and
environmental factors, have been implicated in the aetiology of diabetes [3,4]. This is particularly true
in the case of type 2 diabetes, which accounts for over 90% of all forms of diabetes and where lifestyle
has a profound effect on its manifestation [5]. Usually, lifestyle factors such as diet and physical
activities can be modified in terms of the choices that individuals make. The composition of diet with
respect to the quality of the nutrients including carbohydrates, protein, fats, minerals and vitamins is
important in determining nutritive value and usefulness in human health [6].
1.1. Description of the Intervention
Foods that are composed of carbohydrates which break down quickly during the process of
digestion (such as white bread) and that are rapidly absorbed into the blood stream are often termed
as foods with high glycaemic index (GI) [7–9]. Foods with high GI not only rapidly increase blood
glucose, but also insulin responses following the consumption of food [10]. In contrast, foods with
a low glycaemic index such as legumes, lentils, and oats usually contain carbohydrates which break
down slowly during digestion and are slowly assimilated [8,9]. Therefore, these foods have a slower
impact on blood glucose levels and insulin response.
The GI is a measure of the percentage of the area under curve (AUC) with respect to 2-h
blood glucose following the ingestion of a test diet compared with a standard diet (usually glucose
or bread) [7]. It can also be viewed as a reflection of the relative rate of digestibility of the
available carbohydrates of the food compared with a reference food, which is often glucose [11,12].
Differences exist in literature as to what constitutes a low-GI diet and a high-GI diet. Values such as
GI ≤ 40 and GI ≤ 55 for the low-GI diet and GI ≥ 70 for the high-GI diet have been reported [7,13].
1.2. How the Intervention Might Work
The GI value of food is not based on the characteristics of the individual that consumed it, instead,
it depends on the food consumed [9,14,15]. Therefore, dietary management approaches which target
weight loss and improved glycaemic control (including glycated haemoglobin and fasting blood
glucose) in patients with type 2 diabetes may rely on the use of diets with low glycaemic index
instead of using standard low-fat diet [16]. The foods with low GI may contribute to glycaemic control
compared to foods with high GI through the promotion of insulin sensitivity, reducing fluctuations
in blood glucose levels and reducing daily insulin requirements [8]. While glycated haemoglobin
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(HbA1C) provides a measure of the average glycaemia over the preceding 3 months, the fasting blood
glucose is a measure of blood glucose level following at least 8 h of fasting, and is usually taken before
breakfast [17].
1.3. Why It Is Important to Do This Review
Strategies for managing diabetes often rely on lifestyle modifications, including dietary
interventions and pharmacological approaches. There is also evidence that the consumption of
diets with high glycaemic index and glycaemic load over a long period of time may have implications
for metabolism and health, including chronic hyperglycaemia and hyperinsulinaemia, which can lead
to insulin resistance and diabetes [14]. In addition, studies involving populations in China and the
USA have shown that women with a high intake of food with a high glycaemic index were more at
risk of developing type 2 diabetes compared with women on diets with low glycaemic index [14,18,19].
However, there are inconsistencies and controversies with respect to the use of GI of food as a guide
in the selection of foods for patients with diabetes [8,12,20–22]. Evidence from previous studies on
the role of diets with low GI on health and health-related outcomes have produced mixed results [16].
While some studies have found the high-GI diet to be related to poorer short-term metabolic outcomes,
greater hunger, less satiety, and greater food intake [10], the results from other studies have been
different, either not finding the same association or finding an inverse relationship [12,23]. Jung and
Choi [13] demonstrated the beneficial effects of low-GI diet on glucose control in relatively short-term
trials in patients with type 2 diabetes, although the long-term effects of low-GI diets remain unclear.
This view is further reinforced by Thomas and Elliott [8] who noted that the effects of low-GI diets in
managing patients with diabetes have demonstrated mixed results, from small but clinically useful
effects on the medium-term glycaemic control in diabetes, to only modest secondary benefit. The review
by Thomas and Elliott [8], which was published more than 7 years ago and involved patients with
type 1 and type 2 diabetes, found that there was a significant decrease in HbA1c in a low-GI diet
compared with control. Some of the studies included in this review involved children, and the primary
outcome measures were HbA1c and fructosamine. Another review on glycaemic index and type 2
diabetes included only observational studies [22].
However, the current systematic review is based only on randomised controlled trials and involves
only adults with type 2 diabetes, and the outcomes of interest are HbA1c and fasting blood glucose.
In addition, there is currently no globally agreed form of diet for managing patients with diabetes [8].
Therefore, research on how best to understand the quality and composition of carbohydrates and other
nutrients in foods will be essential in developing diets that will one day be useful to patients with
diabetes and acceptable to the global community.
1.4. Objectives
This is a systematic review and meta-analysis which evaluates the effect of the low-glycaemic
index diet in patients with type 2 diabetes
Research question: Is a low-GI diet effective in improving glycaemia in patients with type 2
diabetes compared with a higher-GI diet?
2. Methods
2.1. Types of Studies
Only studies involving randomised controlled trials were selected for this review (Table 1).
2.2. Types of Participants
The participants in the studies selected were adult patients with type 2 diabetes (Table 2).
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2.3. Types of Interventions
The effect of low-glycaemic index diet was compared with higher-glycaemic index diet or control
(conventional carbohydrate exchange, high-cereal fibre diet, high-wheat fibre diet, standard diabetic
diet, American diabetes association diet) in adult patients with type 2 diabetes. The higher-GI or
control diets were classified as having a higher glycaemic index based on the lower GI values of the
intervention diets (low-GI diet).
2.4. Types of Outcome Measures
The following were the outcome measures of interest:
Blood glucose parameters: Glycated haemoglobin (%), fasting blood glucose (mg/dL).
Search Methods for Identification of Studies
The Population, Intervention, Comparator, Outcomes and Study designs (PICOS) framework
was used to identify articles in the various databases [24,25]. The search terms included synonyms
and Medical Subject Headings (MeSH) and involved the use of Boolean operators (AND/OR) which
allowed the combination of words and search terms (Table 1).
Table 1. Search terms and search strategy.
Patient/Population Intervention Comparator Study Designs CombiningSearch Terms
Patients with diabetes Low-glycaemicindex diet
Higher-glycaemic
index diet or control
Randomised
controlled trial
Patients with diabetes
OR type 2 diabetes OR
diabetes OR diabetes
complications OR
diabetes mellitus,
type 2 OR
diabetes mellitus
Glycaemic index OR
glycemic index OR
glycaemic load OR
glycaemic indices or
glycaemic index
number or glycaemic
index numbers
#1 Randomised
controlled trial OR
controlled clinical trial
OR randomized OR
placebo OR drug
therapy OR randomly
OR trial OR groups
#2 “Animals”
NOT “Humans”
#3 #1 NOT #2
Column 1 and
Column 2 and
Column 3
2.5. Electronic Searches
A number of research databases were used to search for relevant articles for this review.
These included EBSCoHost research databases with links to Health Research databases which
incorporate Academic Search Premier, Medline, the Psychology and Behavioural Sciences Collection,
PSYCInfo, and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) Plus.
In addition, Pubmed was searched for useful articles (Figure 1).
2.6. Searching Other Resources
The Web of Science database which encompasses the BIOSIS citation index was searched for
conference papers, and the reference list of articles were also searched.
2.7. Selection of Studies
Only primary research on randomised controlled studies carried out between 2008 and 2018
were included in this review (Table 2). This period was chosen because the search period for the
previous systematic review and meta-analysis by Thomas and Elliot study [8] ended in March 2009.
Earlier search conducted from 2009 to 2018 did not yield enough studies for the current review.
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In addition, only studies involving adults with type 2 diabetes and the use of the dietary glycaemic
index were included. Studies written in English from across the world have been included as diabetes
is a worldwide problem.
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Therefore, other studies involving pati nts with type 1 diabetes or gestational diabetes and animal
stu es were excluded from th s review (Table 2). Similarly, stu ies involving childre with iabetes or
healthy adults without di betes were also exclud d. Studi s which were not randomised and those
involving dietary supplements have been excluded from this review.
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Table 2. Criteria for considering studies for the review based on the Population, Intervention,
Comparator, Outcomes and Study designs (PICOS) structure.
Inclusion Criteria Exclusion Criteria
Population Adult patients (≥18 years) withtype 2 diabetes
Studies involving patients with type 1 diabetes
or gestational diabetes and animal studies.
Studies involving children with diabetes or
healthy adults.
Intervention Low-glycaemic index diet Studies involving dietary supplements
Comparator Higher-glycaemic index dietand/or control Studies involving additional supplements
Outcomes
Blood glucose parameters:
Glycated haemoglobin, fasting
blood glucose
Qualitative outcomes
Types of study: quantitative Randomised controlled trials
Observational studies
Letters
Comments
Reviews
2.8. Evaluation of Quality
The quality of the peer-reviewed articles was evaluated using the checklists for quantitative
studies [26] and the experience of the authors.
2.9. Data Extraction and Management
Data from the selected articles were extracted separately by all the authors based on an agreed
framework and verified by all the authors following completion.
2.10. Meta-Analysis Methods
The meta-analysis of data was carried out using Review Manager (RevMan) 5.3 software [24].
Changes in means and standard deviations between the baseline values and final results for each
outcome of interest in the low-GI diet and the higher-GI diet or control for the different studies were
determined. In addition, the number of participants in the intervention and control groups in each
study were included in a table and entered into the RevMan software for analysis. A heterogeneity test
was carried out in order to evaluate the evidence of variability of the intervention effects [27]. For the
heterogeneity test, a p value of 0.1 was used to determine statistical significance [27]. The heterogeneity
statistic I2 value was <50 and this indicated low heterogeneity for the studies included in both the
glycated haemoglobin and fasting blood glucose analyses. Therefore, the fixed effects model was used
for both the meta-analysis and the sensitivity tests.
A fail-safe number was also calculated for both outcomes of interest. A sensitivity analysis
involving a repeat of the meta-analysis of studies that were definitely known to be eligible was also
conducted [27]. This process involved removing some of the studies from the primary analysis in order
establish that the findings from the systematic review were not dependent on unclear decisions [27].
In this case, the sensitivity tests were carried out for both glycated haemoglobin and fasting blood
glucose by repeating the meta-analysis after removing the studies with the most weight in order to
confirm whether the results were stable.
2.11. Assessment of Risk of Bias in Included Studies
The assessment tool used for evaluating the risk of bias was a domain-based evaluation tool [27].
The process involved the separate critical assessment of the various domains including the random
sequence generation (selection bias), allocation concealment (selection bias), blinding of participants
and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete
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outcome data (attrition bias), selective reporting (reporting bias), and other bias [27]. The risk of
bias was assessed by Review Manager 5.3 software [24].
3. Results
With respect to the systematic review, only nine articles [28–36] met the criteria for inclusion
(Table 3). However, six of these studies [28–31,35,36] were used for the meta-analysis to test the effect
of low-GI diet on glycated haemoglobin and fasting blood glucose in patients with type 2 diabetes.
The others were excluded as they did not meet the criteria for meta-analysis such as reporting their
results in the form of median and interquartile or not providing data before intervention.
The length of study ranged from 2 weeks to 22 months. In terms of the interventions,
these involved comparing the low-GI diet with the higher-GI diet or control (conventional carbohydrate
exchange, high-cereal fibre diet, high-wheat fibre diet, standard diabetic diet, American diabetes
association diet) (Table 3).
In most of the studies [28,30,34–36] that reported dietary glycaemic index values, the low-GI
diet had significantly (p < 0.05) lower values than the higher-GI diet or the control. The study by
Jenkins et al. [29] also showed that the low-GI diet resulted in lower GI values than the high-cereal
fibre diet, although the level of statistical difference was not stated (Table 3). However, differences in
dietary GI values were not significant (p > 0.05) in one study [31], while data were not available in two
of the studies [32,33] although the authors stated that the intervention diets involved low glycaemic
index or low glycaemic response.
In studies reporting on the effect of dietary GI on the HbA1c levels, diets with low GI were shown
to result in a significant improvement (p < 0.05) in HbA1c levels in two studies [29,30] compared with
the higher-GI diet or the control. One study [33] reported slight improvement in HbA1c in the low-GI
diet group compared with control, while differences between low-GI diet and higher-GI diet or control
were not significantly different in four studies [31,34–36].
The effect of low-GI diets on fasting blood glucose compared to higher-GI diets or control diets
was evident in seven of the studies selected [28–30,32–34,36]. While four studies [28,29,34,36] showed a
greater improvement in fasting blood glucose in the low-GI diet compared with higher-GI diet, some of
the differences were not statistically significant. Furthermore, there was a lower fasting blood glucose
level in the higher-GI diet or control compared with low-GI diet in two studies [30,33]. The fasting
blood glucose levels were not significantly different in the low-GI diet compared with control in one
other study [32].
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Table 3. Summary of studies included in the systematic review.
Citation Length ofStudy
Study
Type
Sample
Size Age (Years)
Diabetes Duration
(Years) Interventions
Glycated
Haemoglobin
(HbA1c) %
Blood Glucose Dietary GlycaemicIndex
Gomes et al. [28] 1 month ParallelDesign 20 # 42.4 ± 5.1
# Low-GI (Glycaemic
Index) diet (4.8 ± 1.5)
higher-GI diet
(4.9 ± 1.6)
Low-GI diet versus
higher-GI diet No data
*# Baseline
Low-GI diet = 148.9 ± 8.2
vs. higher-GI diet
147.8 ± 10.7
30 days
Low-GI diet = 150.8 ± 8.7
vs. higher-GI diet =
157.8 ± 10.4
p = 0.43
## Baseline
Low-GI diet = 63 ± 6 vs.
higher-GI diet = 66 ± 4
30 days
Low-GI diet = 54 ± 4 vs.
higher-GI diet = 72 ± 3
p = 0.005
Jenkins et al. [29] 6 months ParallelDesign 210
# Low-GI diet = 60 (10)
High-cereal fibre
diet = 61 (9)
# Low-GI diet = 8.3 (6.5)
High-cereal fibre
diet = 7.2 (5.9)
Low-GI diet versus
high-cereal fibre diet
Low-GI diet ∆ = −0.5%
(95% CI, −0.61% to
−0.39%) vs. high-cereal
fibre diet ∆ = −0.18%
(95% CI, −0.29%
to −0.07%)
p < 0.001
* (Mean) Week 0
Low-GI diet = 138.8 vs.
high-cereal fibre
diet = 141.2
Week 24
Low-GI diet = 127.7 vs.
high-cereal fibre
diet = 136.8
p = 0.02
#### Week 0
Low-GI diet =
80.8 (79.6–82.0) vs.
high-cereal fibre diet =
81.5 (80.4–82.7)
Week 24
Low-GI diet =
69.6 (67.7–71.4) vs.
high-cereal fibre diet =
83.5 (82.4–84.7)
Jenkins et al. [30] 3 months ParallelDesign 121
## Low-GI legume
diet = 58 (1.3)
High-wheat fibre
diet = 61 (1.0)
## Low-GI legume
diet = 9.2 (8.0)
High-wheat fibre
diet = 8.6 (0.8)
Low-GI legume diet vs.
high-wheat fibre diet
Low GI legume diet
∆ = −0.5% (95%, −0.6%
to −0.4%) vs.
high-wheat fibre diet
∆ = −0.3% (95% Cl,
−0.4 to −0.2%)
p < 0.001
*#### Baseline
Low-GI legume diet =
141 (135–147) (95% CI) vs.
high-wheat fibre diet =
134 (127–141) (95% CI)
End of study
Low-GI legume diet =
132(126–138) (95% CI) vs.
high-wheat fibre diet =
127 (121–133) (95% CI)
p = 0.001
#### Baseline
Low-GI legume diet =
80 (79–82) (95% CI) vs.
high-wheat fibre diet =
78 (77–80) (95% CI)
End of study
Low-GI legume diet =
66 (64–67) (95% CI) vs.
high-wheat fibre diet =
82 (81–83) (95% CI)
p < 0.001
Ma et al. [31] 12 months ParallelDesign 40 # 53.53 ± 8.40 # 9.32 ± 9.66
Low-GI diet vs.
American Diabetes
Association diet (ADA)
## Baseline
Low-GI diet =
8.74 ± 0.29% vs.
baseline ADA diet =
8.1 ± 0.28%
12 months
Low-GI diet =
8.39 ± 0.30% vs.
12-month ADA diet =
7.67 ± 0.28%
p = 0.08
No data
## Baseline
Low-GI diet =
79.35 ± 1.36 vs. ADA
diet = 82.03 ± 1.31
12 months
Low-GI diet =
76.64 ± 1.46 vs. ADA
diet = 80.36 ± 1.40
p = 0.07
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Table 3. Cont.
Citation Length ofStudy
Study
Type
Sample
Size Age (Years)
Diabetes Duration
(Years) Interventions
Glycated
Haemoglobin
(HbA1c) %
Blood Glucose Dietary GlycaemicIndex
Gonçalves Reis
and Dullius [32] 2 weeks
Cross-over
study 12 # 60 ± 8 # 12 ± 7
Low-GI diet vs.
higher-GI diet No data
*# Low-GI diet first day
(127 ± 30) vs. higher-GI
diet (148 ± 62) (p < 0.05)
By the second day FBG
levels had the same
average value
(132 mg/dL) (p = 0.78)
No data
Stenvers et al. [33] 22 months Cross-overstudy 20 # 60 ± 7 ### 5 (1–9)
Low-GR (Glycaemic
Response) liquid
formula versus free
choice (control)
### Baseline
Low-GR =
6.5% (6.1–6.9)
Control = 6.5% (6.2–6.9)
12 weeks
Low-GR =
6.5% (6.3–7.1)
Control = 6.6% (6.3–7.0)
**### Baseline
Low-GR = 7.3 (6.4–8.1)
Control = 6.8 (6.1–7.4)
12 weeks
Low-GR = 7.2 (6.5–7.7)
Control = 7.0 (6.7–7.8)
No data
Visek et al. [34] 3 months Cross–overstudy
20 (12 men +
8 women) # 62.7 ± 5.8 # 7 ± 4.1
Low-GI diet versus
standard diabetic diet
### Low-GI diet =
6.63 (6.08–7.0)%
Standard diabetic diet =
6.45 (6.18–6.91)%
(p > 0.05)
**### Low-GI diet =
6.5 (5.6–8.4)
Standard diabetic diet =
6.7 (6.1–7.5)
(p > 0.05)
### Low-GI diet =
49 (48–51)
Standard diabetic diet =
68 (61–72)
(p < 0.01)
Wolever et al. [35] 12 months ParallelDesign 162
Low-GI diet =
60.6 ± 1.0
Higher-GI diet =
60.4 ± 1.1
No data Low-GI diet vs.higher-GI diet
## Baseline
Low-GI diet =
6.2 ± 0.8%
Higher-GI diet =
6.2 ± 1%
Outcomes
Low-GI diet =
6.34 ± 0.05%
Higher-GI diet =
6.34 ± 0.05%
p > 0.05
No data
## Baseline Low-GI diet
= 60.3 ± 0.4 Higher-GI
diet = 61.5 ± 0.4 Study
Low-GI diet =
55.1 ± 0.4 Higher-GI
diet = 63.2 ± 0.4
p < 0.001
Yusof et al. [36] 12 weeks ParallelDesign 100 53.5 No data
Low-GI diet vs.
conventional
carbohydrate
exchange (CCE)
## Baseline
Low-GI diet =
7.68 ± 1.13%
CCE = 7.51 ± 1.24%
Week 12
Low-GI diet =
7.2 ± 0.1%
CCE = 7.2 ± 0.2%
p > 0.05
**## Baseline
Low-GI diet = 7.33 ± 2.23
CCE = 7.01 ± 1.79
Week 12
Low-GI diet = 7.3 ± 0.3
CCE = 7.7 ± 0.4
p < 0.05
# Week 12 Low-GI diet
= 57 ± 6
Week 12 CCE = 64 ± 5
p < 0.001
Abbreviations: ADA (American Diabetes Association); CCE (conventional carbohydrate exchange); FGB (fasting blood glucose); glycated haemoglobin (HbA1c); GI (glycaemic index);
GR (glycaemic response); low-GR (low glycaemic response); ∆ (change); * (FBG, mg/dL); ** FBG (mmol/L); # (Mean ± SD); ## (mean ± SEM); ### (Median) (25th–75th percentile);
#### (Mean and 95% CI, confidence interval).
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3.1. Assessment of Risk of Bias in Included Studies
In terms of the selection bias (random sequence generation and allocation concealment) 100% of
the studies showed low risk of bias (Figures 2 and 3). With respect to the other risks of bias (blinding,
incomplete outcome data, selective reporting and other potential sources of bias), all the studies
demonstrated 100% low risk of bias or unclear risk of bias (Figures 2 and 3) except for the Gomes et al.
study [17] which demonstrated high risk of bias in relation to the blinding of participants and personnel.
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3.2. Effect of Low Glycaemic Index on Glycated Haemoglobin
The test of the overall effect of the low-GI diet compared to higher-GI diet or control on HbA1c
showed that the low-GI diet was more effective both in the meta-analysis (p < 0.001) and in the
sensitivity test (p < 0.001) (removing the study with the most weight) (Figure 4).
There was low heterogeneity (p = 0.33) in the studies used to evaluate the effect of low-GI diet on
glycated haemoglobin. The I2 test showed I2 = 13% for meta-analysis and I2 = 33% for the sensitivity
test, again, confirming low heterogeneity of the studies included.
The result of the sensitivity test (Figure 4) showed that the effect of the low-GI diet on glycated
haemoglobin was reliable. According to Nfs0.05 = (∑Z/1.64)2 − S (Z representing the Z value of
each single study; S representing the number of all enrolled studies) to calculate the fail-safe number
(Nfs0.05)24, the Nfs0.05 was 16. That is, another 16 negative studies would be needed to reverse this
result, thus indicating that the result is stable.
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3.3. Effect of Low Glycaemic Index on Fasting Blood Glucose
With respect to evaluating the effect of the low-GI diet on fasting blood glucose compared to
the high r-GI diet or control diet, the meta-analysis favoured the low-GI diet. However, while the
differences were significant in e meta-analysis (p < 0.05), this was not so in the sens tivity test
(p = 0.15) (removing the study with the most wei ht) (Figure 5). These sensitivity r sults (Figure 5)
indicate that the effect of the low-GI diet on fasting blood glucose was not very reliable. The fail-safe
number (Nfs0.05) with respect to fasting blood glucose was 5.
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Regarding the heterogeneity test, the high p value (p = 0.36) and the chi-squared statistic (2.04)
relative to the degree of freedom (2) would suggest that there was low heterogeneity between the
studies. This was confirmed by the results of the I2 test. The heterogeneity test for fasting blood glucose
showed I2 = 2% for meta-analysis and I2 = 45% for the sensitivity test, indicating low heterogeneity of
the studies included.
4. Discussion
Based on the findings of the systematic review, the low-GI diet resulted in greater improvement
in glycated haemoglobin [29,30] and fasting blood glucose [28,29,34,36] compared to higher-GI diet
or control in patients with type 2 diabetes. In the study by Yusof et al. [36], although the effect on
HbA1c was not significantly different between the low-GI diet and the higher-GI diet or control,
the improvement within the low-GI group was more pronounced and of clinical benefit. However,
compared with the American Diabetes Association (ADA) diet, the low-GI diet achieved equivalent
control of HbA1c using less medication [31] and for patients on diet alone with optimal glycaemic
control, long-term HbA1c was not affected by altering the GI [35]. The findings of this systematic
review confirm the results of earlier systematic review by Thomas and Elliot [8] which suggests that
lowering the glycaemic index of food may improve glycated haemoglobin in patients with diabetes.
However, the difference between this review and the Thomas and Elliot [8] study is with respect to
the second outcome measure. While fasting glucose was the outcome of interest in this review, it was
fructosamine in the review by Thomas and Elliot [8]. Regarding the risk of bias, 100% of the studies
showed low risk of selection bias while all the studies demonstrated 100% low risk of bias or unclear
risk of bias in relation to blinding, incomplete outcome data, selective reporting, and other potential
sources of bias except for one study that showed a high risk of bias with respect to the blinding of
participants and personnel.
There was no statistically significant difference between the low-GI and higher-GI diets in relation
to HbA1c and fasting blood glucose in the study by Visek et al. [34]. Acute glycaemic control was
variable over the 3-day period in the study by Gonçalves Reis and Dullius [32] following the adoption
of low-GI diet. While the first day of the study demonstrated a significant difference in acute glycaemic
control, differences were not significant on the second or third day [32]. Stenvers et al. [33] found
no beneficial effect of the low-glycaemic response liquid meal with respect to fasting blood glucose.
The differences observed between these studies in terms of their results may be due to the limitations of
using HbA1c in identifying the daily changes in glycaemia [17]. The use of HbA1c may not detect the
harmful effects of excessive postprandial hyperglycaemic excursions and the risk of hypoglycaemia [7].
According to Chiu and Taylor [7], the contribution of postprandial glucose may be up to 70% in
daily hyperglycaemia, and the contribution of fasting glucose increases as glycaemic control worsens.
This may explain why the association between dietary GI and HbA1c is not consistent across studies [7].
Therefore, the use of a meta-analysis of both fasting blood glucose and HbA1c levels to evaluate the
effect of dietary GI in patients with diabetes is a useful strategy of eliminating the limitation of using
HbA1c to assess GI exposure. Other factors to consider include the nature of the starch, particle size,
pH, the amount of fibre, fat, and protein, and the cooking method and time, which may affect the GI
of food and its effect on blood glucose response, and lead to differences in outcomes of studies [15].
The differences in the classification of low- and high-GI diets may also have effect on outcomes of
studies [37].
The Food and Agricultural Organisation [9] has recommended the use of the glycaemic index
of foods in clinical applications in patients with diabetes, and that the glycaemic index be used as
a useful indicator of the impact of food on the blood glucose response. Recently, the American
Diabetes Association (ADA) [38] recommended that patients with diabetes consume carbohydrates
from vegetables, fruits, legumes, whole grains, and dairy products. The ADA [38] also recommended
that emphasis should be placed on foods which are higher in fibre and lower in glycaemic load as
opposed to other sources, especially those with added sugar. The glycaemic load is the product of
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the glycaemic index of food or diet and the grams of available carbohydrate in that food or diet
divided by 100 [9,15]. These recommendations are in line with the findings of the current systematic
review and meta-analysis, which showed that low-GI diets were more effective in controlling glycated
haemoglobin than higher-GI diets. The position of the ADA [38] with respect to the mixed results of
glycaemic index or glycaemic load in patients with diabetes is also true in relation to the findings of
the studies included in this review. Foods with low GI have demonstrated beneficial effects on glucose
control in short-term trials in patients with type 2 diabetes [13]. However, the higher intake of sucrose
or fructose and the long-term use of high-GI diets can place higher metabolic demands on the body in
relation to higher insulin requirements [6,39,40].
5. Strengths and Limitation of the Study
This review used a systematic approach and meta-analysis to provide contemporary evidence on
the positive effects of low glycaemic index diet on fasting blood glucose and glycated haemoglobin.
The limitation is in the number of studies included in the meta-analysis. In addition, most of the
studies had relatively small sample sizes. The availability and inclusion of more studies would have
increased its wider application.
6. Conclusions
The findings of this systematic review and meta-analysis have shown that low-GI diets are more
effective in controlling HbA1c and fasting blood glucose compared with higher-GI diets or control
diets in patients with type 2 diabetes. Although the outcomes of the individual studies were sometimes
different with respect to the variables of interest, the results of the meta-analysis and sensitivity tests
have demonstrated significant differences (p < 0.001 and p < 0.001, respectively) between low-GI diets
and higher-GI diets or control diets in relation to glycated haemoglobin. In addition, differences
between the low-GI diet and the higher-GI diet or control were significant (p < 0.05) with respect to the
fasting blood glucose following meta-analysis.
7. Perspectives for Future Research
It will useful to evaluate the long-term effectiveness of low-glycaemic index diet in patients with
type 2 diabetes.
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